EMD-36789

Single-particle
3.88 Å
EMD-36789
3D View Gallery
Deposition: 10/07/2023
Map released: 09/10/2024
Last modified: 25/06/2025
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-36789

Archive Files (Depositor)

Primary 3D volume (map.gz) Half-map 1 Half-map 2 (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz) Map-8k19 summary report (pdf.gz) Map-8k19 FULL report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

EMDB Files

VA raw map (map) VA resolution mask (mrc)

Neutralization antibody ZCP3B4 bound with SARS-CoV-2 Omicron BA.5 RBD

EMD-36789

Single-particle
3.88 Å
EMD-36789
3D View Gallery
Deposition: 10/07/2023
Map released: 09/10/2024
Last modified: 25/06/2025
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Severe acute respiratory syndrome coronavirus 2, Homo sapiens
Sample: Neutralization antibody ZCP3B4 bound with SARS-CoV-2 Omicron BA.5 RBD
Fitted models: 8k19

Deposition Authors: Tang B, Dang S
Ultrapotent class I neutralizing antibodies post Omicron breakthrough infection overcome broad SARS-CoV-2 escape variants.
Luo M, Zhou R, Tang B, Liu H, Chen B, Liu N, Mo Y , Zhang P, Lee YL, Ip JD, Wing-Ho Chu A, Chan WM, Man HO, Chen Y, To KK, Yuen KY, Dang S, Chen Z
(2024) Ebiomedicine , 108 , 105354 - 105354
PUBMED: 39341153
DOI: doi:10.1016/j.ebiom.2024.105354
ISSN: 2352-3964